Method of treatment of patients having reduced sensitivity to a bcl-2 inhibitor
US-2024182590-A1 · Jun 6, 2024 · US
This page is not indexed by search engines while we improve data quality.
argenx BV — Physics
argenx BV holds 3 patents in Physics, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | argenx BV |
| Technology | Physics |
| Patents in slice | 3 |
| Recent patents in slice | 3 |
| First year | 2023 |
| Last year | 2024 |
Representative patents
Notable publications linking argenx BV to Physics.
Method of treatment of patients having reduced sensitivity to a bcl-2 inhibitor
US-2024182590-A1 · Jun 6, 2024 · US
Method of treatment of patients having reduced sensitivity to a bcl-2 inhibitor
US-2024182590-A1 · Jun 6, 2024 · US
Method of treatment of patients having reduced sensitivity to a bcl-2 inhibitor
US-2024182590-A1 · Jun 6, 2024 · US
Method of treatment of patients having reduced sensitivity to a bcl-2 inhibitor
US-2024182590-A1 · Jun 6, 2024 · US
Recent filings
Latest patents from argenx BV in Physics.
Method of treatment of patients having reduced sensitivity to a bcl-2 inhibitor
US-2024182590-A1 · Jun 6, 2024 · US
Method of treatment of patients having reduced sensitivity to a bcl-2 inhibitor
US-2024182590-A1 · Jun 6, 2024 · US
Method of treatment of patients having reduced sensitivity to a bcl-2 inhibitor
US-2024182590-A1 · Jun 6, 2024 · US
Method of treatment of patients having reduced sensitivity to a bcl-2 inhibitor
US-2024182590-A1 · Jun 6, 2024 · US
Method of treatment of patients having reduced sensitivity to a bcl-2 inhibitor
US-2024182590-A1 · Jun 6, 2024 · US
Related pages
Navigate to parent entity pages.